Schmidt, M. V., J.-P. Schülke, C. Liebl, M. Stiess, C. Avrabos, J. Bock, G. M. Wochnik, H. A. Davies, N. Zimmermann, S. H. Scharf, D. Trümbach, W. Wurst, W. Zieglgänsberger, C. Turck, F. Holsboer, M. G. Stewart, F. Bradke, M. Eder, M. B. Müller and T. Rein: Tumor suppressor down-regulated in renal cell carcinoma 1 (DRR 1) is a stress-induced actin bundling factor that modulates synaptic efficacy and cognition. In: Proceedings of the National Academy of Sciences of the United States of America 108, 41, 17213-17218 (2011).
Wochnik, G. M., J. Rüegg, G. A. Abel, U. Schmidt, F. Holsboer and T. Rein: FK506-binding Proteins 51 and 52 Differentially Regulate Dynein Interaction and Nuclear Translocation of the Glucocorticoid Receptor in Mammalian Cells. In: Journal of Biological Chemistry 280, 6, 4609-4616 (2005).
Rüegg, J., F. Holsboer, C. Turck and T. Rein: Cofilin 1 is revealed as an inhibitor of glucocorticoid receptor by analysis of hormone-resistant cells. In: Molecular and Cellular Biology 24, 21, 9371-9382 (2004).
Binder, E. B., D. Salyakina, P. Lichtner, G. M. Wochnik, M. Ising, B. Pütz, S. Papiol, S. Seaman, S. Lucae, M. Kohli, T. Nickel, H. Künzel, B. Fuchs, M. Majer, A. Pfennig, N. Kern, J. Brunner, S. Modell, T. Baghai, T. Deiml, P. Zill, B. Bondy, R. Rupprecht, T. Messer, O. Köhnlein, H. Dabitz, T. Brückl, N. Müller, H. Pfister, R. Lieb, J. C. Mueller, E. Löhmussaar, T. M. Strom, T. Bettecken, T. Meitinger, M. Uhr, T. Rein, F. Holsboer and B. Müller-Myhsok: Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. In: Nature Genetics 36, 1319-1325 (2004).
Herr, A.S., A. F. Tsolakidou, A. Yassouridis, F. Holsboer and T. Rein: Antidepressants differentially influence the transcriptional activity of the glucocorticoid receptor in vitro. In: Neuroendocrinology 78, 1, 12-22 (2003).
Rosenhagen, M. C., C. Sõti, U. Schmidt, G. M. Wochnik, F. U. Hartl, F. Holsboer, J. C. Young and T. Rein: The heat shock protein 90-targeting drug cisplatin selectively inhibits steroid receptor activation. In: Molecular Endocrinology 17, 10, 1991-2001 (2003).
The Max Planck Society does not take any responsibility for the content of this export.